+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Vaccine Contract Manufacturing Market Research Report by Function (Downstream and Upstream), Type, Applications, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 4857952
  • Report
  • April 2022
  • Region: Global
  • 189 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • Ajinomoto Althea, Inc.
  • Cobra Bio
  • GlaxoSmithKline PLC
  • IDT Biologika
  • LONZA
  • Paragon Bioservices, Inc.
The Global Vaccine Contract Manufacturing Market size was estimated at USD 2,377.50 million in 2021, USD 2,678.30 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 12.82% to reach USD 4,905.00 million by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Vaccine Contract Manufacturing to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Function, the market was studied across Downstream and Upstream. The Downstream is further studied across Analytical & QC studies, Fill & Finish Operations, and Packaging. The Upstream is further studied across Bacterial Expression Systems, Baculovirus/Insect Expression Systems, Mammalian Expression Systems, and Yeast Expression Systems.
  • Based on Type, the market was studied across Attenuated Vaccine, DNA Vaccines, Inactivated Vaccine, Subunit Vaccines, and Toxoid Vaccines.
  • Based on Applications, the market was studied across Human Use and Veterinary.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.

This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Vaccine Contract Manufacturing market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Vaccine Contract Manufacturing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Vaccine Contract Manufacturing Market, including Ajinomoto Althea, Inc., Albany Molecular Research, Inc., Catalent, Inc., Cobra Bio, Cytovance Biologics, FUJIFILM Diosynth Biotechnologies, GlaxoSmithKline PLC, ICON PLC, IDT Biologika, KBI Biopharma, LONZA, Merck KGaA, Paragon Bioservices, Inc., Pfizer, Inc., Pharmaceutical Product Development, LLC, and PRA Health Sciences.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Vaccine Contract Manufacturing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Vaccine Contract Manufacturing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Vaccine Contract Manufacturing Market?
4. What is the competitive strategic window for opportunities in the Global Vaccine Contract Manufacturing Market?
5. What are the technology trends and regulatory frameworks in the Global Vaccine Contract Manufacturing Market?
6. What is the market share of the leading vendors in the Global Vaccine Contract Manufacturing Market?
7. What modes and strategic moves are considered suitable for entering the Global Vaccine Contract Manufacturing Market?
Frequently Asked Questions about the Global Vaccine Contract Manufacturing Market

What is the estimated value of the Global Vaccine Contract Manufacturing Market?

The Global Vaccine Contract Manufacturing Market was estimated to be valued at $2377.5 Million in 2021.

What is the growth rate of the Global Vaccine Contract Manufacturing Market?

The growth rate of the Global Vaccine Contract Manufacturing Market is 12.8%, with an estimated value of $4905.0 Million by 2027.

What is the forecasted size of the Global Vaccine Contract Manufacturing Market?

The Global Vaccine Contract Manufacturing Market is estimated to be worth $4905.0 Million by 2027.

Who are the key companies in the Global Vaccine Contract Manufacturing Market?

Key companies in the Global Vaccine Contract Manufacturing Market include Ajinomoto Althea, Inc., Albany Molecular Research, Inc., Catalent, Inc., Cobra Bio, Cytovance Biologics, FUJIFILM Diosynth Biotechnologies, GlaxoSmithKline PLC, ICON PLC and KBI Biopharma.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Ajinomoto Althea, Inc.
  • Cobra Bio
  • GlaxoSmithKline PLC
  • IDT Biologika
  • LONZA
  • Paragon Bioservices, Inc.

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing demand for vaccines leading to capacity expansion by contract manufacturers
5.1.1.2. Paradigm shift toward cell-based vaccine production
5.1.1.3. Key advantages such as cost and time saving offered by contract services
5.1.1.4. Vaccination coverage across the globe
5.1.2. Restraints
5.1.2.1. Limited outsourcing by well-established vaccine manufacturers
5.1.3. Opportunities
5.1.3.1. Rising global demand to cater to the growing population of varied age groups
5.1.3.2. Innovation and robust vaccine pipeline
5.1.3.3. Favorable government insights and guidelines to speed up the vaccine manufacturing
5.1.4. Challenges
5.1.4.1. Pharma companies manufacturing operations in-house to gain strategic control
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
6. Vaccine Contract Manufacturing Market, by Function
6.1. Introduction
6.2. Downstream
6.2.1. Analytical & QC studies
6.2.2. Fill & Finish Operations
6.2.3. Packaging
6.3. Upstream
6.3.1. Bacterial Expression Systems
6.3.2. Baculovirus/Insect Expression Systems
6.3.3. Mammalian Expression Systems
6.3.4. Yeast Expression Systems
7. Vaccine Contract Manufacturing Market, by Type
7.1. Introduction
7.2. Attenuated Vaccine
7.3. DNA Vaccines
7.4. Inactivated Vaccine
7.5. Subunit Vaccines
7.6. Toxoid Vaccines
8. Vaccine Contract Manufacturing Market, by Applications
8.1. Introduction
8.2. Human Use
8.3. Veterinary
9. Americas Vaccine Contract Manufacturing Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Vaccine Contract Manufacturing Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa Vaccine Contract Manufacturing Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Ajinomoto Althea, Inc.
13.2. Albany Molecular Research, Inc.
13.3. Catalent, Inc.
13.4. Cobra Bio
13.5. Cytovance Biologics
13.6. FUJIFILM Diosynth Biotechnologies
13.7. GlaxoSmithKline PLC
13.8. ICON PLC
13.9. IDT Biologika
13.10. KBI Biopharma
13.11. LONZA
13.12. Merck KGaA
13.13. Paragon Bioservices, Inc.
13.14. Pfizer, Inc.
13.15. Pharmaceutical Product Development, LLC
13.16. PRA Health Sciences
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET: DYNAMICS
FIGURE 2. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2021 VS 2027 (%)
FIGURE 3. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2021 VS 2027 (USD MILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2027
FIGURE 5. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2019-2027 (USD MILLION)
FIGURE 6. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 7. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL & QC STUDIES, 2019-2027 (USD MILLION)
FIGURE 8. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL & QC STUDIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FILL & FINISH OPERATIONS, 2019-2027 (USD MILLION)
FIGURE 10. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FILL & FINISH OPERATIONS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 11. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING, 2019-2027 (USD MILLION)
FIGURE 12. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2019-2027 (USD MILLION)
FIGURE 14. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 15. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY BACTERIAL EXPRESSION SYSTEMS, 2019-2027 (USD MILLION)
FIGURE 16. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY BACTERIAL EXPRESSION SYSTEMS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 17. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY BACULOVIRUS/INSECT EXPRESSION SYSTEMS, 2019-2027 (USD MILLION)
FIGURE 18. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY BACULOVIRUS/INSECT EXPRESSION SYSTEMS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 19. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY MAMMALIAN EXPRESSION SYSTEMS, 2019-2027 (USD MILLION)
FIGURE 20. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY MAMMALIAN EXPRESSION SYSTEMS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 21. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY YEAST EXPRESSION SYSTEMS, 2019-2027 (USD MILLION)
FIGURE 22. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY YEAST EXPRESSION SYSTEMS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 23. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2021 VS 2027 (%)
FIGURE 24. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 25. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2027
FIGURE 26. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY ATTENUATED VACCINE, 2019-2027 (USD MILLION)
FIGURE 27. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY ATTENUATED VACCINE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 28. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DNA VACCINES, 2019-2027 (USD MILLION)
FIGURE 29. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DNA VACCINES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 30. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY INACTIVATED VACCINE, 2019-2027 (USD MILLION)
FIGURE 31. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY INACTIVATED VACCINE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 32. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY SUBUNIT VACCINES, 2019-2027 (USD MILLION)
FIGURE 33. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY SUBUNIT VACCINES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 34. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TOXOID VACCINES, 2019-2027 (USD MILLION)
FIGURE 35. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TOXOID VACCINES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 36. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2021 VS 2027 (%)
FIGURE 37. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2021 VS 2027 (USD MILLION)
FIGURE 38. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2027
FIGURE 39. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY HUMAN USE, 2019-2027 (USD MILLION)
FIGURE 40. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY HUMAN USE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 41. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY VETERINARY, 2019-2027 (USD MILLION)
FIGURE 42. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY VETERINARY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 43. AMERICAS VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 44. ARGENTINA VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 45. BRAZIL VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 46. CANADA VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 47. MEXICO VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 48. UNITED STATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 49. ASIA-PACIFIC VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 50. AUSTRALIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 51. CHINA VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 52. INDIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 53. INDONESIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 54. JAPAN VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 55. MALAYSIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 56. PHILIPPINES VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 57. SINGAPORE VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 58. SOUTH KOREA VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 59. TAIWAN VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 60. THAILAND VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 61. EUROPE, MIDDLE EAST & AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 62. FRANCE VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 63. GERMANY VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 64. ITALY VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 65. NETHERLANDS VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 66. QATAR VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 67. RUSSIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 68. SAUDI ARABIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 69. SOUTH AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 70. SPAIN VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 71. UNITED ARAB EMIRATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 72. UNITED KINGDOM VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 73. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET: FPNV POSITIONING MATRIX
FIGURE 74. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET: SHARE, BY KEY PLAYER, 2021
FIGURE 75. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL VACCINE CONTRACT MANUFACTURING MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. AMERICAS VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. ASIA-PACIFIC VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 9. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL & QC STUDIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 10. AMERICAS VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL & QC STUDIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL & QC STUDIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 12. ASIA-PACIFIC VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL & QC STUDIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL & QC STUDIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 14. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FILL & FINISH OPERATIONS, BY REGION, 2019-2027 (USD MILLION)
TABLE 15. AMERICAS VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FILL & FINISH OPERATIONS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 16. UNITED STATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FILL & FINISH OPERATIONS, BY STATE, 2019-2027 (USD MILLION)
TABLE 17. ASIA-PACIFIC VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FILL & FINISH OPERATIONS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 18. EUROPE, MIDDLE EAST & AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FILL & FINISH OPERATIONS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 19. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING, BY REGION, 2019-2027 (USD MILLION)
TABLE 20. AMERICAS VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 21. UNITED STATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING, BY STATE, 2019-2027 (USD MILLION)
TABLE 22. ASIA-PACIFIC VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 23. EUROPE, MIDDLE EAST & AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 24. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, BY REGION, 2019-2027 (USD MILLION)
TABLE 25. AMERICAS VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 26. UNITED STATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, BY STATE, 2019-2027 (USD MILLION)
TABLE 27. ASIA-PACIFIC VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 28. EUROPE, MIDDLE EAST & AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 29. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY BACTERIAL EXPRESSION SYSTEMS, BY REGION, 2019-2027 (USD MILLION)
TABLE 30. AMERICAS VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY BACTERIAL EXPRESSION SYSTEMS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 31. UNITED STATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY BACTERIAL EXPRESSION SYSTEMS, BY STATE, 2019-2027 (USD MILLION)
TABLE 32. ASIA-PACIFIC VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY BACTERIAL EXPRESSION SYSTEMS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 33. EUROPE, MIDDLE EAST & AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY BACTERIAL EXPRESSION SYSTEMS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 34. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY BACULOVIRUS/INSECT EXPRESSION SYSTEMS, BY REGION, 2019-2027 (USD MILLION)
TABLE 35. AMERICAS VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY BACULOVIRUS/INSECT EXPRESSION SYSTEMS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 36. UNITED STATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY BACULOVIRUS/INSECT EXPRESSION SYSTEMS, BY STATE, 2019-2027 (USD MILLION)
TABLE 37. ASIA-PACIFIC VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY BACULOVIRUS/INSECT EXPRESSION SYSTEMS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 38. EUROPE, MIDDLE EAST & AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY BACULOVIRUS/INSECT EXPRESSION SYSTEMS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 39. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY MAMMALIAN EXPRESSION SYSTEMS, BY REGION, 2019-2027 (USD MILLION)
TABLE 40. AMERICAS VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY MAMMALIAN EXPRESSION SYSTEMS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 41. UNITED STATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY MAMMALIAN EXPRESSION SYSTEMS, BY STATE, 2019-2027 (USD MILLION)
TABLE 42. ASIA-PACIFIC VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY MAMMALIAN EXPRESSION SYSTEMS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 43. EUROPE, MIDDLE EAST & AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY MAMMALIAN EXPRESSION SYSTEMS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 44. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY YEAST EXPRESSION SYSTEMS, BY REGION, 2019-2027 (USD MILLION)
TABLE 45. AMERICAS VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 46. UNITED STATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY YEAST EXPRESSION SYSTEMS, BY STATE, 2019-2027 (USD MILLION)
TABLE 47. ASIA-PACIFIC VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 48. EUROPE, MIDDLE EAST & AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 49. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 50. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY ATTENUATED VACCINE, BY REGION, 2019-2027 (USD MILLION)
TABLE 51. AMERICAS VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY ATTENUATED VACCINE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 52. UNITED STATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY ATTENUATED VACCINE, BY STATE, 2019-2027 (USD MILLION)
TABLE 53. ASIA-PACIFIC VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY ATTENUATED VACCINE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY ATTENUATED VACCINE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 55. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DNA VACCINES, BY REGION, 2019-2027 (USD MILLION)
TABLE 56. AMERICAS VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DNA VACCINES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 57. UNITED STATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DNA VACCINES, BY STATE, 2019-2027 (USD MILLION)
TABLE 58. ASIA-PACIFIC VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DNA VACCINES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 59. EUROPE, MIDDLE EAST & AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DNA VACCINES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 60. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY INACTIVATED VACCINE, BY REGION, 2019-2027 (USD MILLION)
TABLE 61. AMERICAS VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY INACTIVATED VACCINE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 62. UNITED STATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY INACTIVATED VACCINE, BY STATE, 2019-2027 (USD MILLION)
TABLE 63. ASIA-PACIFIC VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY INACTIVATED VACCINE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 64. EUROPE, MIDDLE EAST & AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY INACTIVATED VACCINE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 65. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY SUBUNIT VACCINES, BY REGION, 2019-2027 (USD MILLION)
TABLE 66. AMERICAS VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY SUBUNIT VACCINES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 67. UNITED STATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY SUBUNIT VACCINES, BY STATE, 2019-2027 (USD MILLION)
TABLE 68. ASIA-PACIFIC VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY SUBUNIT VACCINES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY SUBUNIT VACCINES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 70. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TOXOID VACCINES, BY REGION, 2019-2027 (USD MILLION)
TABLE 71. AMERICAS VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TOXOID VACCINES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 72. UNITED STATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TOXOID VACCINES, BY STATE, 2019-2027 (USD MILLION)
TABLE 73. ASIA-PACIFIC VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TOXOID VACCINES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TOXOID VACCINES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 75. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2019-2027 (USD MILLION)
TABLE 76. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY HUMAN USE, BY REGION, 2019-2027 (USD MILLION)
TABLE 77. AMERICAS VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY HUMAN USE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 78. UNITED STATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY HUMAN USE, BY STATE, 2019-2027 (USD MILLION)
TABLE 79. ASIA-PACIFIC VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY HUMAN USE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY HUMAN USE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 81. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY VETERINARY, BY REGION, 2019-2027 (USD MILLION)
TABLE 82. AMERICAS VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY VETERINARY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 83. UNITED STATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY VETERINARY, BY STATE, 2019-2027 (USD MILLION)
TABLE 84. ASIA-PACIFIC VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY VETERINARY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY VETERINARY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 86. AMERICAS VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 87. ARGENTINA VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 88. BRAZIL VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 89. CANADA VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 90. MEXICO VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 91. UNITED STATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 92. ASIA-PACIFIC VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 93. AUSTRALIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 94. CHINA VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 95. INDIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 96. INDONESIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 97. JAPAN VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 98. MALAYSIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 99. PHILIPPINES VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 100. SINGAPORE VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 101. SOUTH KOREA VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 102. TAIWAN VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 103. THAILAND VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 105. FRANCE VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 106. GERMANY VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 107. ITALY VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 108. NETHERLANDS VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 109. QATAR VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 110. RUSSIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 111. SAUDI ARABIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 112. SOUTH AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 113. SPAIN VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 114. UNITED ARAB EMIRATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 115. UNITED KINGDOM VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 116. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET: SCORES
TABLE 117. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET: BUSINESS STRATEGY
TABLE 118. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET: PRODUCT SATISFACTION
TABLE 119. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET: RANKING
TABLE 120. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET: SHARE, BY KEY PLAYER, 2021
TABLE 121. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET: MERGER & ACQUISITION
TABLE 122. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 123. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 124. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET: INVESTMENT & FUNDING
TABLE 125. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 126. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Ajinomoto Althea, Inc.
  • Albany Molecular Research, Inc.
  • Catalent, Inc.
  • Cobra Bio
  • Cytovance Biologics
  • FUJIFILM Diosynth Biotechnologies
  • GlaxoSmithKline PLC
  • ICON PLC
  • IDT Biologika
  • KBI Biopharma
  • LONZA
  • Merck KGaA
  • Paragon Bioservices, Inc.
  • Pfizer, Inc.
  • Pharmaceutical Product Development, LLC
  • PRA Health Sciences
Note: Product cover images may vary from those shown

Loading
LOADING...